JACKSON, Wyo.--(BUSINESS WIRE)--Brand Engagement Network (“BEN”), an emerging provider of personalized customer engagement AI technology and human-like AI avatars, today announced the appointment of Dr. Richard S. Isaacs, MD as medical advisor to its board of directors. Dr. Isaacs is a renowned otolaryngologist, head, neck and skull base surgeon and is currently serving as Dean of the College of Medicine and Professor of Otolaryngology (head and neck oncologic surgery) at California Northstate University, previously having served as the Chief Executive Officer of The Permanente Group for over six years..

杰克逊，Wyo。-品牌参与网络（“BEN”）是一家新兴的个性化客户参与AI技术和类似人类AI化身的提供商，今天宣布任命Richard S.Isaacs博士，医学博士为其董事会的医疗顾问。Isaacs博士是一位着名的耳鼻喉科医生，头颈部和颅底外科医生，目前担任加州北方州立大学医学院院长和耳鼻喉科教授（头颈部肿瘤外科），此前曾担任首席执行官Permanente集团的官员已有六年以上的历史。。

In his role as medical advisor, we believe Dr. Isaacs will bring deep expertise in the medical and healthcare verticals, as well as a broad network, to BEN at a pivotal time as BEN continues towards the consummation of its previously announced business combination with DHC Acquisition Corp. (Nasdaq: DHCA) and public listing on the Nasdaq Capital Market.

作为医疗顾问，我们相信艾萨克斯博士将在医疗和医疗保健领域以及广泛的网络领域带来深刻的专业知识，以便BEN在关键时刻继续完善其先前宣布的与DHC的业务组合收购公司（纳斯达克股票代码：DHCA）并在纳斯达克资本市场上市。

DHC filed its Form S-4 Registration Statement with the Securities and Exchange Commission on October 17, 2023 - marking another critical milestone in BEN’s march towards its public listing on the Nasdaq Capital Market..

DHC于2023年10月17日向美国证券交易委员会提交了S-4注册声明，这标志着本三月在纳斯达克资本市场上市的另一个重要里程碑。。

Michael Zacharski, CEO of BEN, said:

BEN首席执行官Michael Zacharski说：

“We’re thrilled to welcome Dr. Isaacs, a highly influential physician leader and healthcare executive to the BEN team. We believe his extensive expertise in both practicing and teaching medicine as well as running one of the nation’s largest medical groups will be invaluable in helping us achieve our mission of revolutionizing the healthcare industry with our conversational AI platform and human like AI interface.”.

“我们很高兴欢迎博士。艾萨克斯是本团队极具影响力的医生领导者和医疗保健执行官。我们相信，他在实践和教学医学以及运营全国最大的医疗集团之一方面的广泛专业知识将有助于我们通过对话式AI平台和人性化AI界面实现彻底改变医疗行业的使命。

Dr. Richard S. Isaacs, MD said:

医学博士Richard S.Isaacs博士说：

“AI has the potential to transform healthcare by supporting the current workforce, expanding access to care, and bridging the health equity gap. The BEN team is well-equipped to fulfill these promises, as their avatar is highly interactive and genuinely attentive, showcasing what I believe will be an unmatched level of compassion and empathy.”.

“人工智能有可能通过支持现有的劳动力，扩大获得医疗服务的机会，弥合健康公平差距来改变医疗保健状况.BEN团队有能力履行这些承诺，因为他们的化身具有高度互动性和真诚的专注力，展示我相信这将是一个无与伦比的同情和同情水平“。

About BEN

关于本

BEN (Brand Engagement Network) is a leading provider of conversational AI technology and human-like AI avatars headquartered in Jackson, WY. BEN delivers highly personalized, multi-modal (text, voice, and vision) AI engagement, with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands.

BEN（品牌参与网络）是会话AI技术和人类AI化身的领先提供商，总部设在WY.BEN杰克逊，提供高度个性化，多模式（文本，语音和视觉）AI参与，重点关注存在巨大劳动力差距的行业以及改变消费者如何与网络，提供商和品牌互动的机会。

The backbone of BEN’s success is a rich portfolio of conversational AI applications that drive better customer experience, increased automation and operational efficiencies. BEN seeks to partner with companies with complementary capabilities and networks to enable meaningful business outcomes..

BEN成功的支柱是丰富的会话AI应用程序组合，可带来更好的客户体验，提高自动化和操作效率。BEN寻求与具有互补能力和网络的公司合作，以实现有意义的业务成果。。

For more information about BEN, please visit: https://beninc.ai/

有关BEN的更多信息，请访问：https://beninc.ai/

About DHC Acquisition Corp.

关于DHC收购公司。

DHC Acquisition Corp. (Nasdaq: DHCA) is a special purpose acquisition company (SPAC) focused on partnering with an innovative technology company. DHC’s mission is to invest in companies which are charting the future of how humans and business interact at the last mile, spanning enterprise infrastructure, industrial IoT, automation, retail and E-commerce infrastructure, automotive, and aerospace.

DHC收购公司（纳斯达克股票代码：DHCA）是一家专注于与创新技术公司合作的特种收购公司（SPAC）。DHC的使命是投资于描绘人类和企业在最后一英里如何互动的未来的公司，包括企业基础设施，工业物联网，自动化，零售和电子商务基础设施，汽车和航空航天。

We endeavour to enable the applications of innovative technology and business models which bring goods, people, or information to its final destination..

我们努力实现创新技术和商业模式的应用，将商品，人员或信息带到最终目的地。。

DHC’s approach to business is based on teamwork, integrity and quiet professionalism, qualities we learned during our extensive training in the military. We bring our unique hybrid experience and our values into the corporate world, building high performing teams in a range of specialized industries: technology, consumer, aviation, defense, automotive, investment banking, capital markets, and asset management.

DHC的商业方式基于团队合作，诚信和安静的专业精神，我们在军队广泛培训期间学到的品质。我们将独特的混合体验和价值观带入企业世界，在技术，消费者，航空，国防，汽车，投资银行，资本市场和资产管理等一系列专业行业建立高绩效团队。

Our collective experience includes: >25 years as CEOs of public companies, 8 companies founded, 13 companies acquired, and >55 years in military leadership..

我们的集体经验包括：>25年担任上市公司首席执行官，8家公司创立，13家公司收购，55年以上军事领导。。

Important Information About the Business Combination and Where to Find It

有关业务组合以及在何处找到它的重要信息

In connection with the BEN’s announcement of its intent to go public via a merger with DHC Acquisition Corp. (“DHC”) (the “Business Combination”), DHC has filed a registration statement on Form S-4 (the “Form S-4”) with the SEC, which will serve as a preliminary proxy statement of DHC. DHC will mail a definitive proxy statement and other relevant documents to its shareholders.

关于本通过与DHC收购公司（“DHC”）（“业务组合”）合并公开其意图的公布，DHC已与SEC提交了表格s-4（“表格s-4”），这将作为DHC的初步代理声明。DHC将向股东邮寄明确的代理声明和其他相关文件。

DHC’s shareholders and other interested persons are advised to read, when available, the preliminary proxy statement and any amendments thereto and the definitive proxy statement and documents incorporated by reference therein filed in connection with the Business Combination, as these materials will contain important information about DHC, BEN and the Business Combination.

建议DHC的股东和其他感兴趣的人士在可能的情况下阅读初步代理声明及其任何修正案以及其中提及的与商业组合相关的最终代理声明和文件，因为这些材料将包含有关DHC，BEN和商业组合。

When available, the definitive proxy statement and other relevant materials for the Business Combination will be mailed to shareholders of DHC as of a record date to be established for voting on the Business Combination. INVESTORS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT DHC, BEN AND THE BUSINESS COMBINATION.

如果有的话，商业组合的最终代理声明和其他相关材料将作为建立用于商业组合投票的记录日期邮寄给DHC的股东。敦促投资者仔细阅读最终代理声明和其他相关材料，因为它们将包含有关DHC，BEN和业务组合的重要信息。

Shareholders will also be able to obtain copies of the Form S-4, preliminary proxy statement, the definitive proxy statement and other documents filed with the SEC that will be incorporated by reference therein, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to: DHC Acquisition Corp., 1900 West Kirkwood Blvd, Suite 1400B, Southlake, TX 76092 or by emailing chris@integrity.partners..

股东还将能够在SEC的网站上免费获取S-4表格，初步代理声明，最终代理声明和向SEC提交的其他文件的副本，这些文件将通过引用并入其中.SEC.gov，或通过指示请求：DHC Acquisition Corp.，1900 West Kirkwood Blvd，Suite 1400B，Southlake，TX 76092或通过电子邮件chris@integrity.partners..

Participants in the Solicitation

参与征集

DHC, BEN and certain of their directors and executive officers may be deemed participants in the solicitation of proxies from DHC’s shareholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in the Business Combination will be set forth in the Form S-4.

DHC，BEN及其某些董事和执行官可能被视为参与DHC股东就业务组合征集代理的参与者。这些董事和执行官的姓名列表以及他们在商业组合中的利益描述将在表格S-4中列出。

Certain information regarding the directors and executive officers of DHC is contained in its Annual Report on Form 10-K for the fiscal year ended December 31, 2022. These documents can be obtained free of charge from the sources indicated above.

有关DHC董事和执行官的某些信息包含在截至2022年12月31日的财政年度表格10-K的年度报告中。这些文件可以从上述来源免费获得。

Forward-Looking Statements

前瞻性声明

This communication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are not historical facts, and involve risks and uncertainties that could cause actual results of DHC and BEN to differ materially from those expected and projected.

本通讯包含1933年“证券法”第27A条和1934年“证券交易法”第21E条含义内的“前瞻性陈述”，这些陈述不是历史事实，涉及可能导致DHC实际结果的风险和不确定性。本与预期和预期有很大不同。

These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology.

这些前瞻性陈述可以通过使用前瞻性术语来确定，包括“相信”，“估计”，“预期”，“期望”，“意图”，“计划”，“可能”，“潜力”，“项目”，“预测”，“继续”或“应该”，或者在每种情况下，它们的否定或其他变体或可比较的术语。

These forward-looking statements include, without limitation, statements regarding DHC’s ability to enter into definitive agreements or consummate a transaction with BEN and the expected timing of completion of the Business Combination..

这些前瞻性陈述包括但不限于关于DHC达成明确协议或完成与BEN交易的能力以及完成业务组合的预期时间的陈述。。

These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside DHC’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the inability of the Parties to successfully or timely consummate the Business Combination; the risk that the Business Combination may not be completed by DHC’s business combination deadline and the potential failure to obtain an extension of the Business Combination deadline by DHC; failure to realize the anticipated benefits of the Business Combination; risks relating to the uncertainty of the projected financial information with respect to BEN; the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive transaction agreement; BEN’s history of operating losses; BEN’s need for additional capital to support its present business plan and anticipated growth; technological changes in BEN’s market; the value and enforceability of BEN’s intellectual property protections; BEN’s ability to protect its intellectual property; BEN’s material weaknesses in financial reporting; and BEN’s ability to navigate complex regulatory requirements; the ability to maintain the listing of DHC’s securities on a national securities exchange; the ability to implement business plans, forecasts, and other expectations after the completion of the Business Combination; the effects of competition on BEN’s business; the risks of operating and effectively managing growth in evolving and uncertain macroeconomic conditions, such as high inflation and recessionary environments; and continuing risks relating to the COVID 19 pandemic.

这些前瞻性陈述涉及重大风险和不确定性，可能导致实际结果与预期结果大不相同。这些因素大多数不在DHC的控制范围之内，很难预测。可能导致这种差异的因素包括但不限于：各方无法成功或及时完善业务组合；DHC的业务组合截止日期可能无法完成业务组合的风险，以及DHC可能无法延长业务组合截止日期的风险；未能实现业务组合的预期收益；与BEN预计财务信息不确定性有关的风险；发生可能导致终止最终交易协议的任何事件，变更或其他情况；本的经营损失历史；本需要额外资金来支持其目前的业务计划和预期增长；本市场的技术变化；本知识产权保护的价值和可执行性；本保护其知识产权的能力；本在财务报告方面的重大弱点；和BEN处理复杂监管要求的能力；维持DHC证券在全国证券交易所上市的能力；在业务组合完成后实施业务计划，预测和其他期望的能力；竞争对本商业的影响；在高通货膨胀和隐性环境等不断变化和不确定的宏观经济条件下经营和有效管理增长的风险；以及与COVID 19大流行有关的持续风险。

The foregoi.

预言。

DHC and BEN caution that the foregoing list of factors is not exclusive. DHC and BEN caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. None of BEN nor DHC undertakes nor accepts any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

DHC和BEN警告说，上述因素列表不是唯一的。DHC和BEN警告读者不要过分依赖任何前瞻性陈述，这些陈述仅在做出日期时才说话。BEN和DHC均不承诺或承担任何义务或承诺公开发布对任何前瞻性声明的任何更新或修订，以反映其期望的任何变化或任何此类声明所基于的事件，条件或环境的任何变化。

Further information about factors that could materially affect DHC, including its results of operations and financial condition, is set forth under “Risk Factors” in Part I, Item 1A of DHC’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022..

有关可能对DHC产生重大影响的因素的进一步信息，包括其运营结果和财务状况，在第一部分“风险因素”下列出，DHC年度报告中的第1A项，即截至12月31日的财政年度10-K表格，2022年。。

No Offer or Solicitation

没有报价或征求

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities of BEN or DHC or a solicitation of any vote or approval. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended..

本通信不构成出售或征求购买BEN或DHC任何证券的报价或征求任何投票或批准。除符合经修订的1933年“证券法”第10条要求的IPO外，不得提供证券。。